Chronic Lymphocytic Leukemia (CLL) is a slow-growing type of leukemia (blood cancer) in which too many lymphoblasts (immature white blood cells) are found in the blood and bone marrow. Also called chronic lymphoblastic leukemia.
Different treatments are available for those with chronic lymphocytic leukemia (CLL). Some treatments are called standard. This means they are the currently used treatments. Some treatments are being tested in clinical trials. A treatment clinical trial is a study meant to help improve current treatments or obtain information on new treatments.
When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. You may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment, while others are available during or after treatment.
Treatment options vary depending on your situation including the stage of the cancer and other...
The Abramson Cancer Center hosts a wide range of materials and activities that provide education and support to address key areas of concern for cancer patients and their loved ones. We are proud that many of our innovative patient education programs have been recognized by national groups, including the National Cancer Institute's Cancer Patient Education Network.
Our educational materials and support activities help people deal with the physical and emotional consequences of a cancer diagnosis and treatment. They also assist patients and families to resume active lives after treatment.
Our support group meetings provide information on topics of ...
During her week at college orientation at Columbia University in late August 2008, Annalisa Meier, an outgoing, self-reliant teenager, first noticed that she wasn't feeling well.
Focus On Blood Cancers and Bone Marrow Transplant Video
A patient education video with testimonies from our patients, doctors and researchers. Find out more about programs, treatment, research and care that is unique to the Abramson Cancer Center.
Carl June, MD on Patient Power tv discusses Research on the Horizon for Hematologic Malignancies
Alan Gewirtz, MD on Patient Power tv discusses Research on the Horizon for Hematologic Malignancies
5th Annual Focus on Leukemia, Lymphoma and Myeloma Patient Education Conference - click here to view podcasts, photos, and more
Dr. Schuster speaks at ASH: Updates in Lymphoma Research
Dan Vogl speaks live from ASH: Updates on the Treatment of Multiple Myeloma
Dr. Loren speaks at ASH 2008: Breaking News in Chronic Myelogenous Leukemia (CML)
Find a Doctor/Researcher
Make an Appointment
Refer a Patient
Make a Gift
Explore Penn Cancer Network
